CapsoVision CV
NASDAQ CV
$6.80 +0.12 (+1.80%)
At close: Oct 21, 2026 · 4:00 PM EDT

CapsoVision (CV) Current Deferred Revenue (2024 - 2026)

Updated

CapsoVision's Current Deferred Revenue came in at $140,000 for Q2 2026, up 44.3% from $97,000 a year earlier.

Analysis

CapsoVision (CV) Current Deferred Revenue (2024 - 2026) Analysis & Trends

At the end of FY2025, CapsoVision's Current Deferred Revenue was $177,000, up 34.1% from FY2024.

  • Going back by year, Current Deferred Revenue was $132,000 in FY2024.
  • The five-year range for quarterly Current Deferred Revenue is $97,000 (Q2 2025) to $177,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 CapsoVision 339.58 Mn 339.58 Mn 1.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 140,000.00
Dec 31, 2025 177,000.00
Sep 30, 2025 106,000.00
Jun 30, 2025 97,000.00
Dec 31, 2024 132,000.00
API Access

CapsoVision Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CV&period=max&api_key=YOUR_API_KEY